Olympus (OTCMKTS:OCPNY) Stock Price Crosses Below 200 Day Moving Average – Here’s What Happened

Shares of Olympus Co. (OTCMKTS:OCPNY – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares trading hands.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded shares of Olympus to a “buy” rating in a research note on Monday, May 18th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy”.

Get Olympus alerts:

Read Our Latest Stock Report on Olympus

Olympus Stock Down 1.4%

The stock has a market capitalization of $23.15 billion, a price-to-earnings ratio of 21.95, a PEG ratio of 1.07 and a beta of 0.70. The firm’s fifty day moving average is $18.00 and its 200-day moving average is $18.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.99 and a quick ratio of 1.48.

About Olympus

(Get Free Report)

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.

See Also

• Five stocks we like better than Olympus
• These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
• 3 Stocks Under $20 to Buy Before a Broader Market Rally
• Petco Faces Tough Competition, But Momentum Is Building
• The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.